marcel koken
TitleCited byYear
The t (15; 17) translocation alters a nuclear body in a retinoic acid‐reversible fashion.
MH Koken, F Puvion‐Dutilleul, MC Guillemin, A Viron, G Linares‐Cruz, ...
The EMBO journal 13 (5), 1073-1083, 1994
5381994
Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor α degradation
V Lallemand-Breitenbach, J Zhu, F Puvion, M Koken, N Honoré, ...
Journal of Experimental Medicine 193 (12), 1361-1372, 2001
5272001
Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia
J Zhu, MHM Koken, F Quignon, MK Chelbi-Alix, L Degos, ZY Wang, ...
Proceedings of the National Academy of Sciences 94 (8), 3978-3983, 1997
4631997
Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones
H Yssel, JE De Vries, M Koken, W Van Blitterswijk, H Spits
Journal of immunological methods 72 (1), 219-227, 1984
4461984
PML induces a novel caspase-independent death process
F Quignon, F De Bels, M Koken, J Feunteun, JC Ameisen, H de Thé
Nature genetics 20 (3), 259, 1998
4281998
Inactivation of the HR6B ubiquitin-conjugating DNA repair enzyme in mice causes male sterility associated with chromatin modification
HP Roest, J Van Klaveren, J De Wit, CG Van Gurp, MHM Koken, ...
Cell 86 (5), 799-810, 1996
4041996
Molecular characterization of the human excision repair gene ERCC-1: cDNA cloning and amino acid homology with the yeast DNA repair gene RAD10
M van Duin, J de Wit, H Odijk, A Westerveld, A Yasui, MHM Koken, ...
cell 44 (6), 913-923, 1986
3671986
Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor α (RARα) and oncogenic RARα fusion proteins
J Zhu, M Gianni, E Kopf, N Honoré, M Chelbi-Alix, M Koken, F Quignon, ...
Proceedings of the National Academy of Sciences 96 (26), 14807-14812, 1999
3621999
Roscovitine targets, protein kinases and pyridoxal kinase
S Bach, M Knockaert, J Reinhardt, O Lozach, S Schmitt, B Baratte, ...
Journal of Biological Chemistry 280 (35), 31208-31219, 2005
3582005
Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element.
M Stadler, MK Chelbi-Alix, MH Koken, L Venturini, C Lee, A Saib, ...
Oncogene 11 (12), 2565-2573, 1995
3141995
The second zinc-finger domain of poly (ADP-ribose) polymerase determines specificity for single-stranded breaks in DNA.
G Gradwohl, JMM de Murcia, M Molinete, F Simonin, M Koken, ...
Proceedings of the National Academy of Sciences 87 (8), 2990-2994, 1990
3131990
The PML growth-suppressor has an altered expression in human oncogenesis.
MH Koken, G Linares-Cruz, F Quignon, A Viron, MK Chelbi-Alix, ...
Oncogene 10 (7), 1315-1324, 1995
2861995
Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein
MK Chelbi-Alix, F Quignon, L Pelicano, MHM Koken
Journal of Virology 72 (2), 1043-1051, 1998
2641998
PML protein expression in hematopoietic and acute promyelocytic leukemia cells
MT Daniel, M Koken, O Romagne, S Barbey, A Bazarbachi, M Stadler, ...
Blood 82 (6), 1858-1867, 1993
2611993
Induction of the PML protein by interferons in normal and APL cells.
MK Chelbi-Alix, L Pelicano, F Quignon, MH Koken, L Venturini, M Stadler, ...
Leukemia 9 (12), 2027-2033, 1995
2551995
Structural and functional conservation of two human homologs of the yeast DNA repair gene RAD6.
MH Koken, P Reynolds, I Jaspers-Dekker, L Prakash, S Prakash, ...
Proceedings of the National Academy of Sciences 88 (20), 8865-8869, 1991
2551991
Combined arsenic and retinoic acid treatment enhances differentiation and apoptosis in arsenic-resistant NB4 cells
M Giannı̀, MHM Koken, MK Chelbi-Alix, G Benoit, M Lanotte, Z Chen, ...
Blood, The Journal of the American Society of Hematology 91 (11), 4300-4310, 1998
2421998
PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3
M Jeanne, V Lallemand-Breitenbach, O Ferhi, M Koken, M Le Bras, ...
Cancer cell 18 (1), 88-98, 2010
2322010
TIF1γ, a novel member of the transcriptional intermediary factor 1 family
L Venturini, J You, M Stadler, R Galien, V Lallemand, MHM Koken, ...
Oncogene 18 (5), 1209, 1999
1531999
The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homomerisation in vivo.
P Dhordain, O Albagli, S Ansieau, MH Koken, C Deweindt, S Quief, ...
Oncogene 11 (12), 2689-2697, 1995
1391995
The system can't perform the operation now. Try again later.
Articles 1–20